No Data
GeneDx Holdings Price Target Raised to $28.00/Share From $12.50 by Goldman Sachs
GeneDx Holdings Price Target Raised to $28.00/Share From $12.50 by Goldman
Express News | Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $28
Express News | GeneDx Holdings Corp : TD Cowen Raises Target Price to $46 From $24
13D Filings -- Barron's
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
All You Need to Know About GENEDX HOLDINGS (WGS) Rating Upgrade to Strong Buy
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results
Mars MoooOP :